open access

Vol 26, No 1 (2021)
Case report
Published online: 2021-01-22
Submitted: 2021-01-11
Get Citation

Marginal zone lymphoma of the dura — two case reports with long-term follow-up

Felipe de Azevedo Rosas, Sergio Leonardo Favareto, Garles Miller Matias Vieira, Mariana Netto de Oliveira, Felipe D’ Almeida Costa, Douglas Guedes de Castro
DOI: 10.5603/RPOR.a2021.0011
·
Rep Pract Oncol Radiother 2021;26(1):138-142.

open access

Vol 26, No 1 (2021)
Case reports
Published online: 2021-01-22
Submitted: 2021-01-11

Abstract

Primary MALT lymphoma arising at the dura is a rare circumstance with no categorical therapeutic plan in literature. There are few reports available with different treatment courses. Here, we report two cases with a long-term follow-up after the same pattern of management and review the literature.

Abstract

Primary MALT lymphoma arising at the dura is a rare circumstance with no categorical therapeutic plan in literature. There are few reports available with different treatment courses. Here, we report two cases with a long-term follow-up after the same pattern of management and review the literature.

Get Citation

Keywords

marginal zone B-cell lymphoma; dura-mater; central nervous system neoplasm; MALT lymphoma

About this article
Title

Marginal zone lymphoma of the dura — two case reports with long-term follow-up

Journal

Reports of Practical Oncology and Radiotherapy

Issue

Vol 26, No 1 (2021)

Article type

Case report

Pages

138-142

Published online

2021-01-22

DOI

10.5603/RPOR.a2021.0011

Bibliographic record

Rep Pract Oncol Radiother 2021;26(1):138-142.

Keywords

marginal zone B-cell lymphoma
dura-mater
central nervous system neoplasm
MALT lymphoma

Authors

Felipe de Azevedo Rosas
Sergio Leonardo Favareto
Garles Miller Matias Vieira
Mariana Netto de Oliveira
Felipe D’ Almeida Costa
Douglas Guedes de Castro

References (12)
  1. Olszewski AJ, Castillo JJ. Survival of patients with marginal zone lymphoma: analysis of the Surveillance, Epidemiology, and End Results database. Cancer. 2013; 119(3): 629–638.
  2. Zucca E, Conconi A, Roggero E. Non-gastric MALT lymphomas: a survey of 369 European patients. The International Extranodal Lymphoma Study Group. Ann Oncol. 2000; 11(Suppl 4): 1–2.
  3. Zucca E, Bertoni F. The spectrum of MALT lymphoma at different sites: biological and therapeutic relevance. Blood. 2016; 127(17): 2082–2092.
  4. Bustoros M, Liechty B, Zagzag D, et al. A Rare Case of Composite Dural Extranodal Marginal Zone Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. Front Neurol. 2018; 9: 267.
  5. Schaff LR. Updates on Primary Central Nervous System Lymphoma. Curr Oncol Rep. 2018; 20(2): 11.
  6. Kumar S, Kumar D, Kaldjian EP, et al. Primary low-grade B-cell lymphoma of the dura: a mucosa associated lymphoid tissue-type lymphoma. Am J Surg Pathol. 1997; 21(1): 81–87.
  7. A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma. Blood. 1997; 89(11): 3909–3918.
  8. Beltrán BE, Kuritzky B, Quiñones P, et al. Extranodal marginal zone lymphoma of the cranial dura mater: report of three cases and systematic review of the literature. Leuk Lymphoma. 2013; 54(10): 2306–2309.
  9. Kamoshima Y, Sawamura Y, Sugiyama T, et al. Primary central nervous system mucosa-associated lymphoid tissue lymphoma — case report. Neurol Med Chir (Tokyo). 2011; 51(7): 527–530.
  10. Thieblemont C, Zucca E. Clinical aspects and therapy of gastrointestinal MALT lymphoma. Best Pract Res Clin Haematol. 2017; 30(1-2): 109–117.
  11. Yalahom J, Illidge T, Specht L, et al. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the ernational Lymphoma Radiation Oncology Group. Int J RadiationOncology Biol Phys. 2015; 92(1): 11–315.
  12. de la Fuente MI, Haggiagi A, Moul A, et al. Marginal zone dural lymphoma: the Memorial Sloan Kettering Cancer Center and University of Miami experiences. Leuk Lymphoma. 2017; 58(4): 882–888.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: journals@viamedica.pl